Sort by
Refine Your Search
-
program focuses on translational, laboratory-based, and mechanistic studies aimed at understanding how host-microbe interactions impact conditions such as recurrent urinary tract infections (rUTIs) and
-
maps and model building. You should have a Ph.D. and have more than 2 years of experience in cryo-EM data processing and 3D map generation. You will work under the guidance of Dr. Maria Schumacher on a
-
key regulators of inflammation and tissue remodeling in gut and skin diseases. • Apply and refine AI/ML methods, including deep learning, neural networks, and interpretable models (e.g., SHAP, BioMapAI
-
available to conduct research on chronic pain. Using animal pain models, behavioral tests, calcium imaging, patch-clamp, optogenetics, neuroanatomy, molecular biology, the successful candidate is expected
-
therapeutics will be tested in these models, such as vagus nerve stimulation and anti-inflammatory compounds. Some of these scientific questions will further address the complexity of innate immune signaling
-
. Candidates with background knowledge and hands-on experience in mouse models, proteomics, 3D organoids, primary cell purification, and culture skills are particularly welcome. Requirements: A PhD or MD/PhD
-
Postdoctoral position at Duke University is available to conduct research on chronic pain. Using animal pain models, behavioral tests, calcium imaging, patch-clamp, optogenetics, neuroanatomy, molecular biology
-
position is funded by multiple NIH projects, e.g., https://tinyurl.co m/ysxhmujvThe overall goal is to : (1) develop inference and dynamic prediction models using a wide variety of data, including clinical
-
physiology, behavioral analysis, genetic models, chemistry and toxicology to examine the effects of flavor additives in electronic cigarettes and other tobacco products on nicotine use initiation and health
-
. Additionally, research support will be required for ongoing tissue-based trials being conducted within the Khasraw lab. Duties include: · Development of a clinical trial protocol of combination therapy